Plasma calprotectin and risk of cardiovascular disease: Findings from the PREVEND prospective cohort study

There is a log-linear association of calprotectin concentration with risk of CVD, which may be partly dependent on hsCRP. Adding calprotectin to conventional risk factors improves CVD risk assessment using measures of reclassification and −2 log likelihood.